Development of new predictive markers for endocrine therapy and resistance in breast cancer

Author： Henriksen Katrine   Sonne-Hansen Katrine   Kirkegaard Tove   Frogne Thomas   Lykkesfeldt Anne  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.47, Iss.4, 2008-01, pp. : 795-801

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Challenges in defining predictive markers for response to endocrine therapy in breast cancer

By Larionov Alexey A   Miller William R  

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1415-1428

Future Medicine

Access to resources Recommend Favorite

Resistance to endocrine therapy in breast cancer

By Kurebayashi Junichi  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 39-46

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of factors affecting endocrine therapy resistance in breast cancer

By      

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 379-384

Spandidos Publications

Access to resources Recommend Favorite

Endocrine resistance in breast cancer: molecular pathways and rational development of targeted therapies

By Roop Ryan P   Ma Cynthia X  

Future Oncology, Vol. 8, Iss. 3, 2012-03 ,pp. : 273-292

Future Medicine

Access to resources Recommend Favorite

Her-2/neu as Predictive Marker for Endocrine Therapy and Chemotherapy in Patients with Metastatic Breast Cancer

By Köstler Wolfgang J.   Zielinski Christoph C.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-01 ,pp. : 73-84

Springer Publishing Company

Access to resources Recommend Favorite